A. Y. Chang

1.6k total citations
40 papers, 1.3k citations indexed

About

A. Y. Chang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, A. Y. Chang has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in A. Y. Chang's work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (11 papers) and Cancer therapeutics and mechanisms (10 papers). A. Y. Chang is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (11 papers) and Cancer therapeutics and mechanisms (10 papers). A. Y. Chang collaborates with scholars based in United States, Singapore and United Kingdom. A. Y. Chang's co-authors include Daniel D. Karp, Tom Anderson, David H. Johnson, John H. Glick, James E. Herndon, Julian Rosenman, Gerald H. Clamon, Robert Cooper, Mark R. Green and George C. Garrow and has published in prestigious journals such as Journal of Clinical Oncology, Brain and JNCI Journal of the National Cancer Institute.

In The Last Decade

A. Y. Chang

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Y. Chang United States 17 724 494 230 169 127 40 1.3k
Donna E. Levy United States 15 483 0.7× 324 0.7× 256 1.1× 232 1.4× 109 0.9× 24 1.5k
Rosemary Young United Kingdom 10 695 1.0× 199 0.4× 226 1.0× 241 1.4× 135 1.1× 15 1.0k
B. Mirtsching United States 12 1.1k 1.6× 459 0.9× 182 0.8× 104 0.6× 131 1.0× 27 1.3k
Véronique D’Hondt France 21 781 1.1× 335 0.7× 298 1.3× 163 1.0× 144 1.1× 83 1.3k
Thomas Makatsoris Greece 22 1.0k 1.4× 338 0.7× 362 1.6× 135 0.8× 147 1.2× 85 1.5k
Peter Kozuch United States 19 557 0.8× 263 0.5× 259 1.1× 176 1.0× 255 2.0× 42 1.1k
Jey-Hsin Chen United States 6 481 0.7× 256 0.5× 269 1.2× 142 0.8× 104 0.8× 11 1.1k
Edgardo S. Santos United States 21 576 0.8× 524 1.1× 384 1.7× 69 0.4× 88 0.7× 101 1.2k
Daniel A. Rushing United States 20 564 0.8× 771 1.6× 270 1.2× 81 0.5× 283 2.2× 42 1.5k
Gabriel Kacsó Romania 21 301 0.4× 448 0.9× 301 1.3× 74 0.4× 113 0.9× 68 1.2k

Countries citing papers authored by A. Y. Chang

Since Specialization
Citations

This map shows the geographic impact of A. Y. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Y. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Y. Chang more than expected).

Fields of papers citing papers by A. Y. Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Y. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Y. Chang. The network helps show where A. Y. Chang may publish in the future.

Co-authorship network of co-authors of A. Y. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of A. Y. Chang. A scholar is included among the top collaborators of A. Y. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Y. Chang. A. Y. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Metlagel, Zoltan, Jocelyn F. Krey, Mark F. Swift, et al.. (2019). Electron cryo-tomography of vestibular hair-cell stereocilia. Journal of Structural Biology. 206(2). 149–155. 11 indexed citations
2.
Hsu, Benedict You Wei, Miao Wang, Yu Zhang, et al.. (2013). Silica–F127 nanohybrid-encapsulated manganese oxide nanoparticles for optimized T1magnetic resonance relaxivity. Nanoscale. 6(1). 293–299. 42 indexed citations
3.
4.
Lopes, Gilberto, et al.. (2010). Gefitinib in the adjuvant treatment of hepatocellular carcinoma: A pilot study by the Singapore hepatocellular carcinoma consortium.. Journal of Clinical Oncology. 28(15_suppl). TPS210–TPS210. 3 indexed citations
5.
Huynh, Hung, Vy Ngo, Su Pin Choo, et al.. (2009). Sunitinib (SUTENT, SU11248) Suppresses Tumor Growth and Induces Apoptosis in Xenograft Models of Human Hepatocellular Carcinoma. Current Cancer Drug Targets. 9(6). 738–747. 26 indexed citations
6.
Chang, A. Y., Mary Putt, Kishan J. Pandya, et al.. (1998). Induction Chemotherapy of Dibromodulcitol, Adriamycin®, Vincristine, Tamoxifen, and Halotestin® with Methotrexate in Metastatic Breast Cancer. American Journal of Clinical Oncology. 21(1). 99–104. 1 indexed citations
7.
Beck, Thomas, A. Y. Chang, Rudolph M. Navari, et al.. (1997). Oral Ondansetron 8 mg Twice Daily is as Effective as 8 mg Three Times Daily in the Prevention of Nausea and Vomiting Associated with Moderately Emetogenic Cancer Chemotherapy. Cancer Investigation. 15(4). 297–303. 16 indexed citations
8.
Navari, Rudolph M., Stefan Madajewicz, N. Anderson, et al.. (1995). Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo.. Journal of Clinical Oncology. 13(9). 2408–2416. 68 indexed citations
9.
Bonomi, Philip, et al.. (1994). Phase II Trial of Acivicin Versus Etoposide-Cisplatin in Non-Small Cell Lung Cancer. American Journal of Clinical Oncology. 17(3). 215–217. 18 indexed citations
10.
Hsieh, Ruey‐Kuen, A. Y. Chang, László G. Boros, & Robert F. Asbury. (1994). Phase II Study of Ifosfamide, Carboplatin, and Etoposide in Patients with Advanced Non-Small Cell Lung Cancer. American Journal of Clinical Oncology. 17(6). 509–513. 4 indexed citations
11.
Johnson, David H., A. Y. Chang, & David S. Ettinger. (1994). Taxol (paclitaxel) in the treatment of lung cancer: the Eastern Cooperative Oncology Group experience.. PubMed. 5 Suppl 6. S45–50. 12 indexed citations
12.
Chang, A. Y., Z. Nora Tu, George T. Bryan, et al.. (1994). Phase II study of echinomycin in the treatment of renal cell carcinoma ECOG study E2885. Investigational New Drugs. 12(2). 151–153. 13 indexed citations
13.
Chang, A. Y., M Hunt, David Parkinson, Howard S. Höchster, & Thomas J. Smith. (1993). Phase II Trial of Carboplatin in Patients with Metastatic Malignant Melanoma. American Journal of Clinical Oncology. 16(2). 152–155. 16 indexed citations
14.
McDonald, Sandra, A. Y. Chang, Philip Rubin, et al.. (1993). Combined betaseron R (recombinant human interferon beta) and radiation for inoperable non-small cell lung cancer. International Journal of Radiation Oncology*Biology*Physics. 27(3). 613–619. 29 indexed citations
15.
Chang, A. Y., et al.. (1993). Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results. JNCI Journal of the National Cancer Institute. 85(5). 388–394. 298 indexed citations
16.
Chang, A. Y., et al.. (1991). Nasopharyngeal Carcinoma with Bone Marrow Metastasis. American Journal of Clinical Oncology. 14(1). 66–70. 14 indexed citations
17.
Chang, A. Y., et al.. (1989). Continuous Intravenous Infusion of 5-Fluorouracil in the Treatment of Refractory Breast Cancer. American Journal of Clinical Oncology. 12(5). 453–455. 23 indexed citations
18.
Chang, A. Y., Hugh A.�G. Fisher, A. S. D. Spiers, & László G. Boros. (1986). Toxicities of Human Recombinant Interferon-α 2 in Patients with Advanced Prostate Carcinoma. Journal of Interferon Research. 6(6). 713–715. 16 indexed citations
19.
Ettinger, David S., Daniel Finkelstein, Gregory Harper, et al.. (1985). Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study.. PubMed. 69(9). 1033–4. 8 indexed citations
20.
Chang, A. Y., et al.. (1982). Comparison of urographic and cholegraphic contrast enhanced CT liver scanning. Computerized Radiology. 6(5). 257–262. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donna E. Levy Breakdown of academic impact, for papers by Rosemary Young Breakdown of academic impact, for papers by B. Mirtsching Breakdown of academic impact, for papers by Véronique D’Hondt Breakdown of academic impact, for papers by Thomas Makatsoris Breakdown of academic impact, for papers by Peter Kozuch Breakdown of academic impact, for papers by Jey-Hsin Chen Breakdown of academic impact, for papers by Edgardo S. Santos Breakdown of academic impact, for papers by Daniel A. Rushing Breakdown of academic impact, for papers by Gabriel Kacsó
Rankless by CCL
2026